Thanks, Neil and Dave. Revenue for the third quarter came in at $192.4 million, up 13.3% year-over-year. From a channel perspective, retail revenue increased approximately 20% year-over-year, while e-commerce revenue increased approximately 1% versus Q3 of 2023. As Dave mentioned, our e-commerce channel grew in the mid-single-digits on a sales order value basis. Turning to our stores, we added 42 net new stores over the course of the last 12 months, ending the quarter with 269 stores, up from 227 at the end of Q3 2023. Looking at Q3 retail performance on a blended basis, including both new stores and stores open greater than 12 months, retail productivity was 99% as compared to the same period last year. As a reminder, we define retail productivity as the year-over-year change in retail sales per store for the average number of stores open in the period. This metric covers all of our stores, including newer stores and stores open 12 months or more. As such, this metric is impacted by a number of factors, including the timing and composition of store openings year-over-year, as well as the timing of doctor hiring for new stores. For stores that have been open greater than 12 months. We continue to observe strong year-over-year growth. Our new stores continue to deliver strong unit economics performing in line with our target of 35%, four wall margin and 20 month paybacks. For stores open more than 12 months, average revenue per store was 2.2 million, consistent with the first half of the year and performance was in line with our target 35% four wall margin. Over the course of the past year, we added 45 net new eye exam locations, bringing our stores with eye exam capabilities to 228 stores, or 85% of our total fleets. From a channel mix perspective, retail represented 70% of our overall business, consistent with last quarter and up 365 basis points year-over-year versus 67% in Q3 2023. From a customer perspective, we finished Q3 with 2.43 million active customers, which we believe is more reflective of active households and represents an increase of 5.6% on a trailing 12 month basis. We have been pleased to see sequential improvements in year-over-year active customer growth for the past five quarters, as we benefit from the positive returns we're seeing from our marketing investments, we anticipate Q4 will be our highest year-over-year growth in active customers. We also continue to see strength in average revenue per customer, which came in at $305 in Q3 up 7.5% year-over-year. This was driven by a few factors, including a higher mix of our premium lenses such as progressives, continued ramping of both contact lens and eye exam sales, and continued uptake of our higher priced frames. As previously noted, we have multi-user accounts in which one person in the household places an order on behalf of others, and if we look at our customers on an individual basis, we serve 2.56 million individuals, which is up 6.2% on a trailing 12 month basis, and reflects average revenue per individual of $290 up 6.8%. Moving on to gross margin. As a reminder, our gross margin is fully loaded and accounts for a range of costs, including frames, lenses, optical labs, customer shipping, optometrist salaries, store rent and the depreciation of store build outs. Our gross margin also includes stock-based compensation expense for our optometrists and optical lab employees. For comparability, I will be speaking to gross margin, excluding stock-based compensation. Third quarter adjusted gross margin was 54.6% compared to 54.8% in the year ago period down approximately 13 basis points year over year, and in line with the color we provided on our last earnings call. On a year over year basis efficiencies in customer shipping in our own optical labs driven by glasses growth offset the continued strength and contact lenses and eye exams, which have lower gross margin profiles than eyeglasses, but over the medium and long-term are accretive to gross profit dollars. Within the more fixed portion of our cost of goods, we took advantage of a strong pipeline of candidates and hired more optometrists than our original plan for the quarter. That strategic decision, in addition to occupancy associated with our store rollout were the primary sources of modest de-leverage on a year-over-year basis. Investing in doctors and holistic vision care is a core part of scaling our holistic vision care offering and a key driver of lifetime value and customer retention over time. On a sequential basis Q3 gross margin decreased by 150 basis points, reflecting anticipated deleverage in the fixed portion of our cost of goods driven by increased occupancy from opening 13 new stores and a strong hiring quarter for optometrists as well as from a higher mix of contacts and eye exams representing the continued growth in these business lines. Shifting gears to SG&A, as a reminder, SG&A for our business includes three main components, salary expense for our headquarters, customer experience and retail employees, marketing spend, including our home try on program and general corporate overhead expenses. Adjusted SG&A excludes non-cash costs like stock-based compensation expense. Adjusted SG&A in the third quarter came in at a $100.6 million or 52.3% of revenue. This compares to Q3 2023 adjusted SG&A of $93.4 million or 55% of revenue. Within adjusted SG&A marketing spend increased from $19.7 million or 11.6% of revenue to $23.7 million or 12.3% of revenue as we reinvested a portion of our revenue upside into customer acquisition given strong demand signals in September that have continued into Q4. The deleverage from marketing was offset by disciplined expense management and leverage in corporate expenses as non-marketing adjusted SG&A declined as a percent of revenue from 43.3% to 40%. Total adjusted SG&A was up 7.8% with non-marketing adjusted SG&A up just 4.5% year-over-year. Turning now to adjusted EBITDA. In the third quarter, we generated adjusted EBITDA of $17.3 million, representing an adjusted EBITDA margin of 9%, which compares to adjusted EBITDA of $11 million or 6.5% of revenue in the year ago period. This represents approximately 250 basis points of adjusted EBITDA margin expansion, our highest year-to-date. Turning now to our balance sheet, we were free cashflow positive for the sixth consecutive quarter, generating $13 million in Q3 and ended the quarter with a strong balance sheet position reflecting approximately $251 million in cash, which we will continue to deploy deliberately to support our growth and operations. We also have an undrawn credit facility of $120 million that we can increase to $175 million. Now to our outlook, based on our strong third quarter performance and trends in the fourth quarter so far, we're revising our full year 2024 guidance higher to the following. Revenue of $765 million to $768 million, representing approximately 14% to 15% year-over-year growth. Adjusted EBITDA of approximately $73 million at the midpoint of our revenue range, which equates to an adjusted EBITDA margin of 9.5% or approximately 170 basis points of year-over-year expansion, and we are still on track to open 40 new stores this year. As it relates to gross margin, we're still guiding to stability and gross margin in the mid 50s as a percent of revenue. Regarding Q4 gross margin, as a reminder, we typically see a seasonal sequential decline in gross margin from Q3 to Q4 driven by a significant deferral of revenue from the last two weeks of December into Q1 of the following year. We expect the pattern to look similar to last year where gross margin declined by approximately a 100 basis points quarter-over-quarter. Similar to Q3, we anticipate adjusted EBITDA margin expansion in Q4 will be driven by leverage within SG&A supported by ongoing efficiencies and staffing our store and customer experience teams and achieving continued leverage in corporate expenses, while keeping marketing spend consistent as a percent of revenue in the low teens. We're still forecasting stock-based compensation as a percentage of net revenue in 2024 to be approximately 6% compared with 10.5% in 2023. Stock-based compensation for both periods is above our long-term forecast, as a result of the multi-year equity grants to our co-CEOs in 2021. We still anticipate stock-based compensation to normalize to a range of 2% to 4% of net revenue next year. With respect to the fourth quarter or guiding to the following. Revenue between $184 million and $187 million, which represents growth of approximately 14% to 16% year-over-year. From a bottom line perspective, we're guiding to an adjusted EBITDA margin of approximately 7.3% at the midpoint of our range. Thank you again for joining us this morning. With that, Neil, Dave and I are pleased to take your questions. Operator, please open the line for Q&A.